the effectiveness of the nasal airway stent (nastentTM) in sleep apnea syndrome

the effectiveness of the nasal airway stent (nastentTM) in sleep apnea syndrome - NASstudy

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000019423

Enrollment

Registered

2015-10-20

Start date

2015-07-21

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sleep apnea syndrome

Interventions

To evaluate the changes of self synptoms used of a questionnaire survey and AHI used of portable instrument before and after the use of nasal airway devices in one month and three months against sleep

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: sleep apnea syndrome patients(AHI under20 in PSG)who will recieve a treatment of nasal airway device(nastentTM)

Exclusion criteria

Exclusion criteria: the patients who cannot continue the use of the nasal airway stent(nastentTM) or attend a hospital

Design outcomes

Primary

Measure	Time frame
change of AHI after the indication of nasal airway stent(nastentTM) treatment in one month and three months	—

Secondary

Measure	Time frame
frequency of adverse effect after the indication of nasal airway stent(nastentTM)in one month and three months	—

Countries

Japan

Contacts

Public ContactFukunaga koichi

Keio University school of medicine pulmonary devision

k-fuku@jf7.so-net.ne.jp03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026